Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/1996
11/28/1996WO1996037623A1 Retroviral vectors
11/28/1996WO1996037619A1 Method for reproducing in vitro the rna-dependent rna polymerase and terminal nucleotidyl transferase activities encoded by hepatitis c virus (hcv)
11/28/1996WO1996037616A1 Alphavirus rna replicon systems
11/28/1996WO1996037512A1 Cyclic peptide antifungal agents
11/28/1996WO1996037511A1 Cyclic peptides antifungal agents
11/28/1996WO1996037510A1 Cyclic peptide antifungal agents
11/28/1996WO1996037508A1 Protegrins
11/28/1996WO1996037499A1 Novel cephem derivatives
11/28/1996WO1996037485A1 2-amino-benzoxazinones for the treatment of viral infections
11/28/1996WO1996037475A1 Method for making quinolone carboxylic acids or naphthyridine carboxylic acids in free base form
11/28/1996WO1996037233A1 Polymyxin conjugates
11/28/1996WO1996037228A1 Antibacterial-wound healing compositions and methods for preparing and using same
11/28/1996WO1996037222A1 Vaccine composition containing polyribosylribitol phosphate and method for making same
11/28/1996WO1996037221A1 Subunit vaccine against flavivirus infection
11/28/1996WO1996037220A1 cDNA CLONE FOR SOUTH AFRICAN ARBOVIRUS NO. 86
11/28/1996WO1996037219A1 Abundant extracellular products and methods for their production and use
11/28/1996WO1996037210A2 Pharmaceutical compositions, based on etheric oils obtained from plants for use in the human and veterinary medical field
11/28/1996WO1996037205A1 Remedy for endotoxinemia and multiple organ failure induced thereby
11/28/1996WO1996037204A1 Inhibitors of farnesyl-protein transferase
11/28/1996WO1996029413A3 Dna encoding human papilloma virus type 18
11/28/1996CA2222475A1 Protegrins
11/28/1996CA2222034A1 2-amino-benzoxazinones for the treatment of viral infections
11/28/1996CA2221701A1 Inhibitors of farnesyl-protein transferase
11/28/1996CA2221155A1 Cdna clone for south african arbovirus no. 86
11/28/1996CA2220944A1 Cyclic peptide antifungal agents
11/28/1996CA2220728A1 Cyclic peptide antifungal agents
11/28/1996CA2220688A1 Cyclic peptide antifungal agents
11/28/1996CA2219778A1 Polymyxin conjugates
11/27/1996EP0744406A2 Cyclic peptide antifungal agents
11/27/1996EP0744405A2 Cyclic peptide antifungal agents
11/27/1996EP0744404A2 Cyclic peptide antifungal agents
11/27/1996EP0662835B1 New pharmaceutical formulations of spiramycine
11/27/1996CN1136776A Oral formulations of antifungal
11/27/1996CN1136555A Nerve amide compound, its preparing method and its use
11/26/1996US5578742 Inhibit uncontrolled cell proliferation, treatment of psoriasis, aids, cancer, antitumor
11/26/1996US5578729 Dimeric arylisoquinoline alkaloid compounds
11/26/1996US5578720 Ethanol, methanol and propanol solvates; antibiotics
11/26/1996US5578634 1H-indole-3-acetic acid hydrazide sPLA2 inhibitors
11/26/1996US5578617 Method and compositions for treating age related disorders
11/26/1996US5578615 Administering viricide to patient
11/26/1996US5578608 Hiv protease inhibitor
11/26/1996US5578604 Bactericides
11/26/1996US5578592 Cephalosporin derivatives
11/26/1996US5578591 Effective against grampositive and gramnegative organisms
11/26/1996US5578585 Pleuromutilin derivative complexes
11/26/1996US5578579 Treatment of gastrointestinal disorders
11/26/1996US5578572 Anti-gram-positive bacterial methods and materials
11/26/1996US5578448 Polymerase chain reaction
11/26/1996CA2033448C Antiherpes compositions and method of use
11/21/1996WO1996036638A1 Xanthines and their therapeutic use
11/21/1996WO1996036628A1 6-carboxamido dihydropyran derivatives
11/21/1996WO1996036366A1 Gene therapy for effector cell regulation
11/21/1996WO1996036356A1 Viral agent associated with mystery swine disease
11/21/1996WO1996036351A1 Use of ribavirin and interferon alpha for the treatment of hepatitis c
11/21/1996WO1996036345A1 An anti-aids semifluid extract of traditional chinese medicines and preparation thereof
11/21/1996WO1996036324A2 Use of a pharmaceutically acceptable oxalate derivative in the manufacture of a medicament for the treatment of skin conditions
11/21/1996WO1996036311A1 Use of glyceryl triacetate for treating onychomycoses
11/21/1996WO1996029407A3 Cellubrevin homologs
11/21/1996DE19518262A1 Die Verwendung von Glyceryltriacetat zur Behandlung von Onychomykosen The use of glyceryl triacetate for the treatment of onychomycosis
11/21/1996CA2221314A1 Use of ribavirin and interferon alpha for the treatment of hepatitis c
11/21/1996CA2221305A1 Gene therapy for effector cell regulation
11/21/1996CA2220754A1 6-carboxamido dihydropyran derivatives
11/21/1996CA2220687A1 Use of a pharmaceutically acceptable oxalate derivative in the manufacture of a medicament for the treatment of skin conditions
11/21/1996CA2218548A1 Xanthines and their therapeutic use
11/21/1996CA2195455A1 Use of glyceryl triacetate for treating onychomycoses
11/20/1996EP0743364A2 Nucleic acid fragments derived form the HIV-1 genome, corresponding fragments and their application as reactives for risk evaluation of HIV-1 mother-foetal transmission
11/20/1996EP0743059A2 Process for applying antibacterial oral composition to dental implant areas
11/20/1996EP0742834A1 Method of preparing a viral vector by homologous intermolecular recombination
11/20/1996EP0742791A1 Macrocyclic difluorostatone derivatives useful as antiviral agents
11/20/1996EP0742790A1 Substituted purines and oligonucleotide cross-linking
11/20/1996EP0658103B1 Beads having a core coated with an antifungal and a polymer
11/20/1996EP0627009B1 Macrocyclic lactones and a productive strain thereof
11/20/1996EP0430968B1 Compounds, compositions and method for binding bio-affecting substances to surface membranes of bio-particles
11/20/1996CN1136328A Analog of haemophilus HIN47 with reduced protease activity
11/20/1996CN1136312A Heterocyclic benzenesulfonylimine derivatives as inhibitors of IL-1 action
11/20/1996CN1136277A Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infections
11/20/1996CN1136276A Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections
11/19/1996US5576429 5-substituted pyrimidine nucleosides and nucleotides
11/19/1996US5576420 Subtilin variant of enhanced stability and activity
11/19/1996US5576355 Inhibiting human t-cell leukemia/lymphoma virus
11/19/1996US5576312 1-azatricyclo[7.2.0.03,8 ]undec-2-ene-2-carboxylates as antibacterial compounds
11/19/1996US5576025 Gastrointestinal mucosa-adherent matrixes, pharmaceutical preparations and a coating composition
11/19/1996US5576003 Ornithobacterium rhinotracheale vaccine and method of immunization
11/19/1996US5576002 Meningococcal polysaccharide conjugate vaccine
11/19/1996US5576000 Envelope protein of hiv with sequences
11/19/1996US5575993 Useful as herbicides, microbiocides, plant growth regulators, pharmaceuticals, disinfectants, algicides, sanitizers, and preservatives
11/19/1996US5575652 Process for applying antibacterial oral composition to dental implant areas
11/19/1996CA2096315C Human rotaviruses, vaccines and methods
11/19/1996CA1338728C Cyclosporins and their use a pharmaceuticals
11/14/1996WO1996035953A1 Combinatorial synthesis and high-throughput screening of a rev-inhibiting arylidenediamide array
11/14/1996WO1996035797A1 Hbv vectors and cells for producing the same
11/14/1996WO1996035793A1 Animal gene therapy
11/14/1996WO1996035774A2 Angiostatin fragments and aggregate angiostatin and methods of use
11/14/1996WO1996035720A1 Heavy metal salts of succinic acid hemiesters with hyaluronic acid, or hyaluronic acid esters, a process for their preparation, and relative pharmaceutical compositions
11/14/1996WO1996035714A1 Peptide compounds which inhibit metalloproteinase and tnf liberation and their therapeutic uses
11/14/1996WO1996035712A1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use
11/14/1996WO1996035711A1 Peptide compounds which inhibit metalloproteinase and tnf liberation, and their therapeutic use
11/14/1996WO1996035702A1 Dialkyltiacumicin compounds
11/14/1996WO1996035701A1 Antibiotics
11/14/1996WO1996035700A1 Saccharopeptides and derivatives thereof
1 ... 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 ... 1798